Community/Retail

Elizabeth K Rende DNP, RN, CPNP-PC, PMHS-BC, FAANP of Duke Pediatric Neurology discussed 2 types of headaches—primary and secondary—in an interview filmed at the 2019 National Association of Pediatric Nurse Practitioners conference in New Orleans.

Pharmacists and interns who prepare HDs or work in areas where these drugs are located are potentially at risk for these adverse health effects. It is important for us to understand the risks and be proactive about protecting ourselves.

Mary Jean Ohns, DNP, APRN, CPNP, CCRN, of Toledo Children's Hospital addresses frequent concerns that parents express when a child has a fever, in an interview filmed during the 2019 National Association of Pediatric Nurse Practitioners annual conference in New Orleans.

Norris Turner, PharmD, PhD, vice president of Strategic Alliances and Measures at PQA, discusses value-based contracts and the demand for medication measurements in Medicaid during the Pharmacy Quality Alliance Annual Meeting in Baltimore, MD.

Matthew Pickering, PharmD, RPh, PQA Senior Director of Research & Quality Strategies at Pharmacy Quality Alliance discusses what pharmacists bring to patient care in the Pharmacy Quality Alliance Annual Meeting in Baltimore, MD.

Matthew Pickering, PharmD, RPh, PQA Senior Director of Research & Quality Strategies at Pharmacy Quality Alliance discusses its medication access framework for quality measurement during the Pharmacy Quality Alliance Annual Meeting in Baltimore, MD.

Laura Cranston, RpH, CEO of Pharmacy Quality Alliance (PQA), discusses the organization's origins as a measure developer during the PQA Annual Meeting in Baltimore, MD.

Officials with the FDA have approved alpelisib (Piqray, Novartis) tablets, to be used in combination with the endocrine therapy fulvestrant, to treat postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer following progression on or after an endocrine-based regimen.

Lisa Hines, PharmD, vice president of Measurement and Operations at Pharmacy Quality Alliance (PQA), discusses PQA's new opioid measures and how they complement existing measures during the Pharmacy Quality Alliance Annual Meeting in Baltimore, MD.